Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
04/2001
04/11/2001CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives
04/11/2001CN1064344C Process for producing N-butyraldehyde and/or N-butanol
04/10/2001US6215030 Catalytic reduction of acids, esters and anhydrides to alcohols
04/10/2001US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease
04/10/2001US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia
04/10/2001US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof
04/10/2001US6214877 Antidiabetic agents; modulator of glucose concentration
04/10/2001CA2119661C New n-benzylpiperazine compounds, their preparation process and pharmaceutical compositions containing them
04/10/2001CA2077252C Methods of making ureas and guanidines, and intermediates therefor
04/05/2001WO2001023497A1 Organic electroluminescent element
04/05/2001WO2001023369A2 Process for preparing benzoic acids
04/05/2001WO2001023350A1 Thioalkylamine derivatives and process for the preparation thereof
04/05/2001WO2000050398A3 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
04/05/2001WO1996018391B1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
04/05/2001DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
04/04/2001EP1088029A1 Geminally substituted amines
04/04/2001EP1087954A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
04/04/2001EP1087953A1 Nitrate salts of antihypertensive medicines
04/04/2001EP1087935A1 Anthracene derivatives as anti-cancer agents
04/04/2001EP1087934A1 Aminocyclohexyl ether compounds and uses thereof
04/04/2001EP1087933A1 Method for the catalytic, symmetric disubstitution of carboxylic acid amides with grignard reagents
04/04/2001EP1087932A1 Catalytic titanium (iv) oxide induced geminal asymmetric dialkylation of carboxylic acid amides
04/04/2001EP1087931A1 Method for symmetrically and asymmetrically disubstituting carboxylic acid amides with organotitanates and grignard reagents
04/04/2001EP1087930A1 Method for catalytically disubstituting carboxylic acid amides with at least one grignard reagent
04/04/2001EP1087929A1 Method for producing combinatory amine libraries
04/04/2001EP1087928A1 Catalytic titanium(iv) oxide induced geminal symmetric dialkylation of carboxylic acid amides
04/04/2001EP1087927A1 Method for the catalytic, asymmetric disubstitution of carboxylic acid amides with two different grignard reagents
04/04/2001EP0929216A4 Method of treating post menopausal diseases, including osteoporosis
04/04/2001EP0876326B1 Process for producing amines from olefins on zeoliths of types ssz-26, ssz-33, cit-1 or mixtures thereof
04/04/2001EP0824515B1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them
04/04/2001CN1290258A Arylpiperazines having activity at the serotnin 1A receptor
04/04/2001CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases
04/03/2001US6211364 Process for preparing indane-like compounds
04/03/2001US6211242 Benzamide derivatives as vasopressin antagonists
04/03/2001US6211240 O-benzyl oxime ether derivatives and their use as pesticides
04/03/2001US6211228 Compositions and methods for treating mast-cell mediated conditions
04/03/2001US6211183 Selective factor Xa inhibitors
04/03/2001US6211175 Cardiac diseases improving method
03/2001
03/29/2001WO2001022078A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures
03/29/2001WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp)
03/29/2001WO2001021586A1 Metallo-organo catalyst for polymerizing unsaturated compounds
03/29/2001WO2001021584A1 Tyrosine derivatives
03/29/2001WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
03/29/2001WO2001021577A2 Melanin concentrating hormone antagonist
03/29/2001WO2001002350A3 Novel amino sulfonamides and amido sulfonamides as antiviral agents
03/29/2001WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's)
03/29/2001DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
03/29/2001CA2386474A1 Melanin concentrating hormone antagonist
03/28/2001EP1086700A2 A solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same
03/28/2001EP1086178A1 An anthraquinone and its derivatives
03/28/2001EP1086088A2 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
03/28/2001EP1086079A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
03/28/2001EP1086078A1 Neuropeptide y5 receptor antagonists
03/28/2001EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
03/28/2001EP1086073A1 Method for preparing alkoxyamines from nitroxides
03/28/2001EP1085894A1 Beta 3-adrenergic receptor agonists
03/28/2001EP1085889A2 Novel therapeutic agents that modulate endothelin receptors
03/28/2001EP1085887A2 Novel angiotensin receptor modulators and their uses
03/28/2001EP1085872A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-$g(k)B
03/28/2001EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
03/28/2001EP1085868A1 H1-histamine receptor antagonists
03/28/2001EP1085867A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
03/28/2001EP1085847A2 Novel therapeutic agents that modulate estrogen receptors
03/28/2001CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound
03/28/2001CN1289322A Hydroxamic and carboxylic acid derivatives
03/27/2001US6207829 Cyclization of a corresponding pyrazole compound
03/27/2001US6207716 Non-steroidal ligands for the estrogen receptor
03/27/2001US6207693 Benzamide derivatives having a vasopressin antagonistic activity
03/27/2001US6207665 To treat inflammatory disorders in humans
03/22/2001WO2001019809A1 Tryptase inhibitors
03/22/2001WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors
03/22/2001WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
03/22/2001WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/22/2001WO2000061134A8 Antimicrobial agents
03/22/2001WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection
03/22/2001WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors
03/22/2001DE19944993A1 Metallorganische Katalysatoren für die Polymerisation ungesättigter Verbindungen Organometallic catalysts for the polymerization of unsaturated compounds
03/22/2001CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors
03/22/2001CA2384763A1 Tryptase inhibitors
03/21/2001EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/21/2001EP1085009A1 Indan derivatives
03/21/2001EP1083921A1 Novel leukotriene receptor antagonists and their uses
03/21/2001EP1083917A1 Novel analgesic agents
03/21/2001EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors
03/21/2001EP1083889A2 Method for treating neurodegenerative disorders
03/21/2001EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS
03/21/2001EP0599886B1 Macromonomers having reactive end groups
03/21/2001CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion
03/20/2001US6204306 Alpha-aminoacetophenones functionalized with organic diisocyanates, which can be used as reactive photoinitiators;
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols
03/20/2001US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation
03/20/2001US6203982 Dna of a 3' flanking region of synthase gene; drug screening; antitumor/anticarcinogenic agents; viricides; antiarthritic agents; antiischemic agents; prevention of restenosis; treatment of autoimmune disease
03/20/2001US6203721 For grafting a substituted difluoromethyl group onto a compound containing electrophilic group
03/20/2001CA2158399C Novel pharmaceutical product
03/20/2001CA2132841C Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
03/20/2001CA2071529C Diaromatic substituted anti-aids compounds
03/15/2001WO2001018011A1 Calcium complex of phosphorus containing ethylenediamine derivatives
03/15/2001WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase